Prabhakara Rao Burma

Director Clinical Programming And Data Science at Vincerx Pharma

Prabhakara Rao Burma has extensive work experience in the pharmaceutical industry. Prabhakara rao is currently serving as the Director of Clinical Programming and Data Science at Vincerx Pharma since May 2021. Prior to this, from October 2020 to May 2021, they worked as the Associate Director of Clinical Programming at Bristol Myers Squibb/Myokardia. From October 2018 to October 2020, they held the position of Principal SAS Analyst at Acerta Pharma, a member of the AstraZeneca Group. Before that, from June 2015 to October 2018, they worked as a Lead SAS Programmer (consultant) at Acerta Pharma B.V. (also a member of the AstraZeneca Group). Prabhakara also has experience as a Lead SAS Programmer (Consultant) at Onyx Pharmaceuticals from July 2013 to June 2015 and as an Analyst at Mylan from June 2007 to December 2009.

Prabhakara Rao Burma has a diverse educational background. Prabhakara rao holds a Master of Science (MS) degree in Data Analytics from Colorado State University Global. Prabhakara rao also completed a certificate in Biostatistics from UC San Diego Extended Studies. Prabhakara has a Master's degree in chemistry from the University of Hawaii at Manoa and a Bachelor's degree from Vijayawada Jobs, where they studied Mathematics, Physics, and Chemistry. Moreover, they pursued a Master's degree in Chemistry from the University of Hyderabad.

In addition to their formal education, Prabhakara has obtained two certifications from SAS. Prabhakara rao holds a Base SAS Certification and a Clinical SAS Certification. However, specific details about when and where they obtained these certifications are not provided.

Location

Tracy, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Vincerx Pharma

Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer.


Industries

Employees

51-200

Links